Antidepressant-like Effect of l-perillaldehyde in Stress-induced Depression-like Model Mice through Regulation of the Olfactory Nervous System by Ito, N. et al.
Hindawi Publishing Corporation
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 512697, 5 pages
doi:10.1093/ecam/nen045
Original Article
Antidepressant-like Effectofl-perillaldehydein
Stress-inducedDepression-like Model Mice through
Regulation of the Olfactory Nervous System
N. Ito,1 T. Nagai,1,2 T. Oikawa,1 H.Yamada,1,2 andT.Hanawa1
1Oriental Medicine Research Center, The Kitasato Institute, Japan
2Kitasato Institute for Life Sciences and Graduate School of Infection Control Sciences, Kitasato University, Tokyo, Japan
Correspondence should be addressed to T. Hanawa, hanawa-t@kitasato.or.jp
Received 13 September 2007; Accepted 30 May 2008
Copyright © 2011 N. Ito et al. This is an open access article distributed under the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Perillae Herba (a leaf of Perilla frutescens) has been prescribed as one of the component herbs in certain Kampo (Japanese herbal)
medicines that are used clinically for the improvement of depressive mood. l-Perillaldehyde (PAH) is a major component in the
essential oil containing in Perillae Herba, but its antidepressant-like eﬀect has not been reported. To clarify the antidepressant-like
eﬀect of PAH, the inhaled eﬀect of PAH on stress-induced depression-like model mice prepared by subjection to a combination of
forced swimming and chronic mild stresses was investigated. The degree of the depression-like state was measured by the animal’s
duration of immobility using a forced swimming test. Inhalation of PAH (0.0965 and 0.965 mg/mouse/day, 9 days) signiﬁcantly
shortened the duration of immobility of the depression-like model mice and did not aﬀect locomotor activity. However, another
odorsubstance,cinnamaldehydecontaininginCinnamomiCortex,exhibitednoreductionintheimmobility.Thereductioninthe
immobility induced by the inhalation of PAH was prevented on anosmia-induced mice prepared by intranasal irrigation with zinc
sulfate. These results suggest that the inhalation of PAH shows antidepressant-like activity through the olfactory nervous function.
1.Introduction
Depression is a long-lasting mental disorder, and the preva-
lence for lifetime estimates with the majority in the range
of 8–12% in 10 countries in Europe, the U.S. and Asia [1].
Patients with depression are often prescribed antidepressa-
nts, but antidepressants have adverse eﬀects such as dysuria,
digestive dysfunction and sexual dysfunction. Therefore,
safer and more eﬀective treatments for depression are nee-
ded.
In an animal model using a forced swimming test (FST),
it wasreported that the odor of lemon has an antidepressant-
like property [2]. This ﬁnding suggests that the sensory
action via the olfactory nervous system might be associated
with the antidepressant-like eﬀect. Therefore, it is expected
that treatments for depression using odor inhalation will
be developed. When patients themselves decoct and take
Kampo (Japanese herbal) medicines, they can inhale the
odor of the decoction, indicating that pharmacological
eﬀects of the odor via the olfactory nervous system may be
expected.
Perillae Herba is prescribed as one of the component
herbs of such Kampo medicines as kososan (Xiang-Su-San
in Chinese) and hangekobokuto (Banxia-Houpo-Tang in
Chinese), which are used clinically for the improvement of
depressive mood and in which antidepressant-like activities
have been reported experimentally [3, 4]. It has also been
reported thattheadministration of rosmarinic acidorcaﬀeic
acid containing in Perillae Herba exhibited antidepressant-
likeactivitiesinananimalmodelofdepression[5].However,
the antidepressant-like eﬀect of l-perillaldehyde (PAH),
which is a major component of essential oil containing in
Perillae Herba, has not been reported.
The present study investigated whether the inhalation of
PAH shows an antidepressant-like activity by using stress-
induceddepression-likemodelmice.Theantidepressant-like
activity of PAH through the olfactory nervous system was
also studied by using anosmia-induced model mice.
2.MaterialsandMethods
2.1. Animals. Seven-week-old male ddY mice (Japan SLC,
Hamamatsu, Japan), weighing 35–40 g, were used. The mice2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Structure of l-perillaldehyde (PAH).
werehousedunderconditionsofconstanttemperature(23 ±
2◦C), humidity (55 ± 10%) and a 12 h light cycle (lights on
at 8:00) with food and water available ad libitum. All animal
experimentswereperformedaccordingtotheGuideforCare
and Use of Laboratory Animals at The Kitasato Institute and
Kitasato University.
2.2. Drugs and Reagents. l-Perillaldehyde (PAH; Figure 1)
(Aldrich Chemical Co. Ltd., St. Louis, MO) was diluted in
0.1, 1.0 and 10% (v/v) with ethanol, and cinnamaldehyde
(CAH) (Wako Pure Chemical Industries, Osaka, Japan)
was also diluted in 10% (v/v) with ethanol. Toledomin
(milnacipran hydrochloride) (Asahi Kasei Pharma Corp.,
Tokyo, Japan) was suspended in distilled water. ZnSO4
(Wako) was dissolved in 5% (w/v) with saline. Isovaleric acid
(Wako) was diluted in 1% (v/v) with water.
2.3. Drug Treatment. T h em i c ew e r em a d et oi n h a l eP A H
(0.1, 1.0 and 10%) or CAH (10%) by dropping the solution
on an area between the nose and eyes in a volume of
10µl/mouse once daily at days 1, 2, 4, 5, 6, 7, 8, 9 and
11 (9 times) (Scheme 1(a)). Milnacipran hydrochloride
(MIL) (60mg/kg) was administered orally to the mice by
intragastric gavage in a volume of 0.5ml/mouse once daily
at days 1, 2, 4, 5, 6, 7, 8, 9 and 11 (9 times).
2.4. Stress-Induced Depression-Like Model Mice. The stress-
induced depression-like model mice [3] were prepared by
a combination of modiﬁed forced swimming (FS) twice
with 11-day interval [6, 7] and chronic mild stress (CMS)
[8, 9]. Brieﬂy, the mice were individually placed into 5l glass
beakers (height 27cm, diameter 18cm) ﬁlled with 4 of
water (23 ± 1◦C) for 15min. The beakers were separated by
non-transparent panels to prevent the mice from seeing each
other. After 15min in the water, the mice were removed and
allowed to dry with a drier before being returned to their
home cages. The mice were then separated into groups by
measuring the duration of immobilities for the ﬁrst 5 min
of FS to minimize the variability of immobility among the
groups. A mouse was judged to be immobile when it ceased
struggling and remained ﬂoating motionless in the water,
making only those movements necessary to keep its head
above water. After 2 days, the mice were exposed to CMS,
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Scheme 1: Schedule for the drug treatment on stress-induced
depression-like model mice (a) and preparation of anosmia-
induced mice (b). (a) Brieﬂy, mice were individually placed into
water for 15 min (forced swimming; FS). After 2 days, the mice
were exposed to chronic mild stress (CMS 1, CMS 2 and CMS 3),
which consisted of three diﬀerent stress situations. The mice were
then placed again into water at 60 min after the ﬁnal treatment of
thedrug,andthetotaldurationofimmobilityduringa5minforced
swimming test (FST) was measured. Drugs were treated at days 1,
2, 4, 5, 6, 7, 8, 9 and 11 (9 times). (b) Brieﬂy, intranasal irrigation
with20µlof5%ZnSO4 wasperformedslowlyintothebilateralnose
under light anesthesia 2 days before FS. After exposure to stresses
(mentionedabove), thetotaldurationofimmobilityduringa5min
FSTwasmeasured.Followingday,thetimewhichthemicespenton
t h e1 %i s o v a l e r i ca c i ds i d ew a sm e a s u r e df o r5m i ni nt h eZ n S O 4-
lesioned test (ZLT). Drugs were treated as same schedule as above
(9 times).
which consisted of three diﬀerent stress situations: tilting
of the cage twice 30 degrees from the horizontal (CMS 1),
pouring 200ml of water onto the sawdust bedding of the
cage (CMS 2) and shaking the cages at 200rpm by a Green S.
Seriker II (Vision Scientiﬁc, Kyunggi, Korea) (CMS 3). These
stresssituationswereappliedfor48,24and24h,respectively,
with 24h intervals (Scheme 1). The mice were then placed
again into water at 60min after the ﬁnal treatment of the
drug, and the total duration of immobility during a 5 min
FST was measured.
2.5. Spontaneous Locomotor Activity Test. The spontaneous
locomotor activities of the mice were evaluated by the
open ﬁeld test. Brieﬂy, the mice were individually placed
in the center of an open ﬁeld (40 × 40 × 20cm) with the
ﬁeld divided into 25 equal squares (Sanki Kagaku Kogei,
Kawasaki, Japan) and allowed to move freely for 15 min. The
total number of line crosses for the ﬁrst 5min were counted
to minimize the variability of the total number of line crosses
among the groups. Eleven days later, the mice were again
individually placed in the open ﬁeld and the total numbersEvidence-Based Complementary and Alternative Medicine 3
of line crosses were counted during a 5 min interval 60min
after the ﬁnal drug treatment.
2.6.Anosmia-InducedMice. Anosmiawasinducedaccording
to the modiﬁed method of Alberts and Galef [10]. Brieﬂy,
intranasal irrigation with 20µlo f5 %Z n S O 4 was performed
slowly into the bilateral nose under light anesthesia with
Nembutal (Dainippon Pharmaceutical Co., Ltd, Osaka,
Japan) 2 days before FS. The control mice were intranasally
perfused with saline (Scheme 1(b)).
2.7. ZnSO4-Lesioned Test (ZLT). T h ed e g r e eo fa n o s m i aw a s
evaluated by a behavior of escape from a bad smell [11].
Brieﬂy, the mice were individually placed into the center of
an emptied cage in which a center line had been drawn.
Kimwipe soaked in 1% isovaleric acid solution, which is a
bad smell essence, was placed on one side of the line, and
kimwipe soaking water on the other side. One day after FST,
the time which the mice spent on the 1% isovaleric acid
side was measured for 5min (Scheme 1(b)). If anosmia had
been induced in the mice, which meant they showed a low
perception of odor, the latency of the 1% isovaleric acid side
of the mice was longer than that of the control mice.
2.8. Statistical Analysis. All data were expressed as the
mean ± standard error of the mean (SEM). Results were
analysed by one-way analysis of variance (ANOVA). Post hoc
comparisons, if applicable, were carried out using Fisher’s
PLSD, Dunnett’s or Tukey’s tests. P-values less than .05 (P
< .05) were considered indicative of signiﬁcance.
3. Results
3.1. Inhalation of PAH, but Not CAH, Reduces the Immo-
bility of Stress-Induced Depression-Like Model Mice in
the FST. Sixty minutes after the last inhalation, PAH
(0.0965 and 0.965mg/mouse/day) signiﬁcantly reduced the
duration of immobility in a dose-dependent manner as
compared with the vehicle-treated mice (P < .05 and
P < .01, resp.) (Figure 2(a)). However, the inhalation of
CAH (1.05mg/mouse/day) did not reduce the duration
of immobility as compared with the vehicle-treated mice
(Figure 2(b)).
3.2. Inhalation of PAH Does Not Aﬀect the Spontaneous
Locomotor Activity of Mice. Sixty minutes after the last
inhalation, PAH (0.00965, 0.0965 and 0.965mg/mouse/day)
did not change the total counts (177.6 ± 23.6, 165.8 ±
19.2 and 190.4 ± 19.5, resp.) of line crosses for 5 min as
compared with the vehicle-treated mice (173.5 ± 31.9) (data
not shown).
3.3. Behavioral Veriﬁcation of Anosmia-Induced Mice. The
latency of the ZnSO4-treated mice on the 1% isovaleric acid
side was signiﬁcantly increased compared with the saline-
treated mice under the stress-free condition (P < .01); how-
ever, the latency of the ZnSO4-treated mice was not changed
under the stress condition compared with the stress-free
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Figure 2: Eﬀects of the inhalation of PAH and/or CAH on the
duration of immobility of stress-induced depression-like model
mice in the FST. (a) After treatments of PAH (0.00965, 0.0965 and
0.965mg) for 9 days, the duration of immobility was measured.
(b) After treatments of PAH (0.965mg) and CAH (1.05mg) for
9 days, the duration of immobility was measured. Each column
represents the mean ± SEM of 8–10 mice per group. ∗P < .05 and
∗∗P < .01 with Dunnett’s test (a) or Fisher’s PLSD test (b). CAH,
cinnamaldehyde.
condition (Figure 3(a)). The duration of immobility of the
ZnSO4-treated mice in the FST was signiﬁcantly increased
under the stress condition compared with the stress-free
condition; however, the duration of immobility under the
stress condition was not changed in the ZnSO4-treated mice
compared with the saline-treated mice (Figure 3(b)). More-
over, the increase of immobility under the stress condition
was shortened by oral administration of an antidepressant,
MIL, in the ZnSO4-treated mice (data not shown).4 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Inﬂuences of ZnSO4 on the latency of 1% isovaleric acid
sidein theZLT (a)and theduration ofimmobilityof stress-induced
depression-like model mice in the FST (b). Each column represents
the mean ± SEM of 10–11 mice per group. ∗P < .01 with Fisher’s
PLSD test. ZLT, ZnSO4-lesioned test.
3.4. Reduction of Immobility due to Inhalation of PAH Is
Blocked in Anosmia-Induced Mice. Under the stress con-
dition, the reduction of immobility by the treatment of
PAH (0.965mg/mouse/day) was signiﬁcantly prevented in
the anosmia-induced mice (P < .01; Figure 4).
4. Discussion
In the present study, we have shown that the inhalation of
PAH containing in Perillae Herba showed an antidepressant-
like eﬀect in the stress-induced depression-like model mice,
and that its eﬀect was exhibited via the olfactory nervous
system.
It is considered diﬃcult to design inhaled doses of PAH
bothbecauseinhaleddrugsarenotdirectlyadministeredinto
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Figure 4: Eﬀects of PAH on the duration of immobility in
the FST against anosmia-induced depression-like model mice.
After treatments of PAH (0.965mg) for 9 days, the duration of
immobility was measured. Each column represents the mean ±
SEM of 10–11 mice per group. ∗P < .01 with Tukey’s test.
the body and because the sensitivity of the olfactory nervous
system varies between humans and rodents. In our study,
PAH was inhaled at a dose which was approximately 1.3–
130 times lower than the concentration of PAH containing
in the water-extract of Perillae Herba (2g) in kososan, which
is used clinically as a one day dosage [12], because rodents
have more sensitive olfaction than humans. The inhalation
of PAH reduced the immobility in a dose-dependent manner
(Figure 2(a)), and did not aﬀect spontaneous locomotor
activity (data not shown), indicating that the inhalation of
PAH shows an antidepressant-like property. However, CAH,
which is a major component of the essential oil containing
in Cinnamomi Cortex, did not reduce the immobility in the
present study (Figure 2(b)), and it has also been reported
that essential oils such as jasmine, ylang-ylang, clove, san-
dalwood,peppermint,lavender,rose,camphorandpinehave
noeﬀectsonimmobility[2].Theseresultssuggestthatnotall
essentialoilshaveanantidepressant-likeeﬀect.Inthepresent
study,wedemonstratedtheunprecedentedtreatmentofPAH
by dropping it on an area between the nose and eyes in
mice. The advantages of this treatment are that each mouse
can inhale a constant dose of essential oil, and the mice
are not exposed excessively to additional stress against a
novel environment, as they are in the method of inhalation
in which an apparatus is used for essential oil application
[2]. Conversely, since the essential oil was directly dropped
onto the area between the nose and eyes, the possibility
that the cutaneous absorption of PAH contributed to its
antidepressant-like eﬀect cannot be excluded. Therefore, we
investigated whether the antidepressant-like eﬀect of PAH
is blocked in the mice lesioned olfactory nervous system
with the intranasal irrigation of ZnSO4. When the degree
of anosmia by the treatment of ZnSO4 was veriﬁed inEvidence-Based Complementary and Alternative Medicine 5
the behavioral experiment, the ZnSO4-treated mice had
a signiﬁcant disruption of the olfactory nervous function
(Figure 3(a)). Moreover, histological lesion of the olfactory
nervous system was also observed in the ZnSO4-treated mice
by immunohistochemical study (data not shown). Several
studies have reported that many characteristic depressive
behaviors (disrupted circadian patterns in sleep and feeding;
increased irritability and hyperactivity responses to a novel,
stressful environment) observed in olfactory-bulbectomized
animals are not detected in ZnSO4-treated mice [13–15]. In
the present study, the immobility of the ZnSO4-treated mice
in the FST was not diﬀerent from that of the vehicle-treated
mice(Figure 3(b)).Moreover,theoraladministrationofMIL
(serotonin-noradrenaline reuptake inhibitor) signiﬁcantly
exhibited the reduction of immobility compared with the
vehicle-treated mice in the anosmia-induced mice (data not
shown). These results indicate that mice in which anosmia is
induced by ZnSO4 c a nb eu s e dt ot e s tb e h a v i o r a lp h a r m a c o -
logicalstrategiesfordepression.Thereductionofimmobility
induced by the inhalation of PAH in olfactory-unlesioned
depression-like model mice was blocked in the anosmia-
induced mice. These results suggest that the inhalation of
PAH exhibits an antidepressant-like eﬀect via the olfactory
nervous system, but not via cutaneous absorption.
The oral administration of PAH also exhibited an
antidepressant-like eﬀect in the depression-like model mice,
although its eﬀective doses of PAH (24 and 120mgkg−1)
were very high compared with those for the inhaled study
(data not shown). Although it has been reported that the
oral administration of PAH acted on the central nervous
system [13], the antidepressant-like activity of PAH has
never been reported. This study represents the ﬁrst report
showing the antidepressant-like eﬀect of PAH inhalation.
In the present study, it is not, however, known whether
PAH in the Perillae Herba contributes to the antidepressant-
like activity of Kampo medicines such as kososan and
hangekobokuto containing Perillae Herba as one of the
component herbs. From the report that citrus fragrance
contributes to the reduction of doses of antidepressants in an
animal experiment [2], the combination of antidepressants
and odors may be useful for exhibiting the antidepressant
eﬀects in a synergistic manner. Our ﬁnding, as well as the
report that the odor of lemon exhibits an antidepressant-
like eﬀect [2], together present scientiﬁc evidence of the
antidepressant-like eﬀect of the odor.
Further investigation of the mechanism of PAH on the
antidepressant-like eﬀect is now in progress.
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